Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anu Vähäniemi, Maritta Välimäki, Virve Pekurinen, Minna Anttila & Tella Lantta. (2019) Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach. Neuropsychiatric Disease and Treatment 15, pages 1239-1248.
Read now
Read now
G. Remington, J. Lee, O. Agid, H. Takeuchi, G. Foussias, M. Hahn, G. Fervaha, L. Burton & V. Powell. (2016) Clozapine’s critical role in treatment resistant schizophrenia: ensuring both safety and use. Expert Opinion on Drug Safety 15:9, pages 1193-1203.
Read now
Read now
Mathias Zink & Christoph U Correll. (2015) Glutamatergic agents for schizophrenia: current evidence and perspectives. Expert Review of Clinical Pharmacology 8:3, pages 335-352.
Read now
Read now
Francisco Torres-González, Inmaculada Ibanez-Casas, Sandra Saldivia, Dinarte Ballester, Pamela Grandón, Berta Moreno-Küstner, Miguel Xavier & Manuel Gómez-Beneyto. (2014) Unmet needs in the management of schizophrenia. Neuropsychiatric Disease and Treatment 10, pages 97-110.
Read now
Read now
Tim Kendall, Naomi Glover, Clare Taylor & Stephen Pilling. (2011) Quality, bias and service user experience in healthcare: 10 years of mental health guidelines at the UK National Collaborating Centre for Mental Health. International Review of Psychiatry 23:4, pages 342-351.
Read now
Read now
Michael Rawlins. (2011) Ten years of NICE mental health guidelines. International Review of Psychiatry 23:4, pages 311-313.
Read now
Read now
Articles from other publishers (42)
Bodyl A. Brand, Elske J. M. Willemse, Iris M. H. Hamers & Iris E. Sommer. (2023) Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders. Current Psychiatry Reports 25:11, pages 723-733.
Crossref
Crossref
Susanna Burgess-Barr, Emily Nicholas, Bethany Venus, Niharika Singh, Abigail Nethercott, Gemma Taylor & Pamela Jacobsen. (2023) International rates of receipt of psychological therapy for psychosis and schizophrenia: systematic review and meta-analysis. International Journal of Mental Health Systems 17:1.
Crossref
Crossref
Atefeh Akbari, Hamid Sharif Nia, Mehran Zarghami, Paria Azari, Fatemeh Hendouei & Narjes Hendouei. (2023) A Medication Assessment Tool to Evaluate Prescribers’ Adherence to Practice Guidelines in Acute-Phase Schizophrenia Treatment: Development and Psychometric properties. Iranian Journal of Psychiatry and Behavioral Sciences 17:1.
Crossref
Crossref
Valerio Ricci, Franca Ceci, Francesco Di Carlo, Ilenia Di Muzio, Laura Ciavoni, Monica Santangelo, Gabriele Di Salvo, Mauro Pettorruso, Giovanni Martinotti & Giuseppe Maina. (2023) First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation. Psychiatry Research 320, pages 115053.
Crossref
Crossref
Antonio Vita, Andrea Fagiolini, Giuseppe Maina, Claudio Mencacci, Edoardo Spina & Silvana Galderisi. (2023) Achieving long-term goals through early personalized management of schizophrenia: expert opinion on the role of a new fast-onset long-acting injectable antipsychotic. Annals of General Psychiatry 22:1.
Crossref
Crossref
Wondim Ayenew, Getahun Asmamaw & Teshome Bitew. (2021) Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis. International Journal of Neuropsychopharmacology 24:12, pages 956-964.
Crossref
Crossref
V. Ricci, F. Ceci, F. Di Carlo, A. Lalli, L. Ciavoni, A. Mosca, G. Sepede, A. Salone, D. Quattrone, S. Fraticelli, G. Maina & G. Martinotti. (2021) Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study. Drug and Alcohol Dependence 229, pages 109118.
Crossref
Crossref
Juan Wang, Feng Jiang, Yulong Zhang, Robert O. Cotes, Yating Yang, Zhiwei Liu, Xiaoshuai Ning, Tingfang Liu, Yuanli Liu, Yi-lang Tang & Huanzhong Liu. (2021) Patterns of antipsychotic prescriptions in patients with schizophrenia in China: A national survey. Asian Journal of Psychiatry 62, pages 102742.
Crossref
Crossref
Wolfgang Gaebel, Johannes Stricker, Alkomiet Hasan, Peter Falkai, John S. McIntyre & Ariane Kerst. (2021) The revised DGPPN and APA schizophrenia guidelines: Guideline quality and recommendations for long-term antipsychotic treatment. Schizophrenia Research 229, pages 137-139.
Crossref
Crossref
Matti Isohanni, Erika Jääskeläinen, Brian J. Miller, Anja Hulkko, Jari Tiihonen, Hans‐Jurgen Möller, Sirpa Hartikainen, Sanna Huhtaniska & Johannes Lieslehto. (2020) Medication management of antipsychotic treatment in schizophrenia—A narrative review. Human Psychopharmacology: Clinical and Experimental 36:2.
Crossref
Crossref
Wolfgang Gaebel, Johannes Stricker & Mathias Riesbeck. (2020) The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples. Schizophrenia Research 225, pages 4-14.
Crossref
Crossref
Wolfgang Gaebel, Peter Falkai & Alkomiet Hasan. (2020) The revised German evidence‐ and consensus‐based schizophrenia guideline. World Psychiatry 19:1, pages 117-119.
Crossref
Crossref
Pamela McPherson, Marc Colon & Hannah Scott. 2020. Handbook of Dual Diagnosis. Handbook of Dual Diagnosis
475
504
.
Wolfgang Gaebel, Mathias Riesbeck, Veronica W. Larach, Peter Falkai & Jürgen Zielasek. 2019. Advances in Psychiatry. Advances in Psychiatry
603
619
.
Filip Spaniel, Eduard Bakstein, Jiri Anyz, Jaroslav Hlinka, Tomas Sieger, Jan Hrdlicka, Natálie Görnerová & Cyril Höschl. (2018) Relapse in schizophrenia: Definitively not a bolt from the blue. Neuroscience Letters 669, pages 68-74.
Crossref
Crossref
Rosa-Elena Ulloa, Sofía Arce, Gamaliel Victoria, Emmanuel Sarmiento, Israel Jiménez, Eduardo Arroyo, Ana-Teresa Díaz Calvo, Miriam Del Valle, Gabriela Santos, Marcos Rosetti & Rogelio Apiquian. (2017) Effectiveness of a treatment guideline for schizophrenia in adolescents: Lessons from a middle-income country. Australian & New Zealand Journal of Psychiatry 52:2, pages 192-199.
Crossref
Crossref
Johanna Immonen, Erika Jääskeläinen, Hanna Korpela & Jouko Miettunen. (2017) Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis. Early Intervention in Psychiatry 11:6, pages 453-460.
Crossref
Crossref
Enrico Biagi, Enrico Capuzzi, Fabrizia Colmegna, Alessandra Mascarini, Giulia Brambilla, Alessandra Ornaghi, Jacopo Santambrogio & Massimo Clerici. (2017) Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly. Advances in Therapy 34:5, pages 1036-1048.
Crossref
Crossref
Nosa Godwin Igbinomwanhia, Sunday Osasu Olotu & Bawo Onesirosan James. (2016) Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria. Therapeutic Advances in Psychopharmacology 7:1, pages 3-10.
Crossref
Crossref
Wolfgang Gaebel, Mathias Riesbeck, Andrea Siegert, Harald Zäske & Jürgen Zielasek. 2017. The Stigma of Mental Illness - End of the Story?. The Stigma of Mental Illness - End of the Story?
537
549
.
Ilan Fischler, Sanaz Riahi, Melanie I. Stuckey & Philip E. Klassen. (2016) Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study. BMC Health Services Research 16:1.
Crossref
Crossref
Sangeeta Dey, David B Menkes, Zuzana Obertova, Sreemanti Chaudhuri & Graham Mellsop. (2016) Antipsychotic prescribing and its correlates in New Zealand. Australasian Psychiatry 24:4, pages 360-364.
Crossref
Crossref
Louise C. Johns, Joseph E. Oliver, Mizanur Khondoker, Majella Byrne, Suzanne Jolley, Til Wykes, Candice Joseph, Lucy Butler, Thomas Craig & Eric M.J. Morris. (2016) The feasibility and acceptability of a brief Acceptance and Commitment Therapy (ACT) group intervention for people with psychosis: The ‘ACT for life’ study. Journal of Behavior Therapy and Experimental Psychiatry 50, pages 257-263.
Crossref
Crossref
Wolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, Ansgar Klimke, Matthias Eickhoff, Martina von Wilmsdorff, Walter de Millas, Wolfgang Maier, Stephan Ruhrmann, Peter Falkai, Heinrich Sauer, Andrea Schmitt, Michael Riedel, Stefan Klingberg & Hans-Jürgen Möller. (2016) Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia. Schizophrenia Research 170:1, pages 168-176.
Crossref
Crossref
Lucy Butler, Louise C. Johns, Majella Byrne, Candice Joseph, Emma O’Donoghue, Suzanne Jolley, Eric M.J. Morris & Joseph E. Oliver. (2016) Running acceptance and commitment therapy groups for psychosis in community settings. Journal of Contextual Behavioral Science 5:1, pages 33-38.
Crossref
Crossref
Wolfgang Gaebel & Juergen Zielasek. 2016. Person Centered Psychiatry. Person Centered Psychiatry
345
361
.
Wolfgang Gaebel & Jürgen Zielasek. (2015) Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry and Clinical Neurosciences 69:11, pages 661-673.
Crossref
Crossref
Emmanuelle Peters, Tessa Crombie, Deborah Agbedjro, Louise C. Johns, Daniel Stahl, Kathryn Greenwood, Nadine Keen, Juliana Onwumere, Elaine Hunter, Laura Smith & Elizabeth Kuipers. (2015) The long-term effectiveness of cognitive behavior therapy for psychosis within a routine psychological therapies service. Frontiers in Psychology 6.
Crossref
Crossref
Suzanne Jolley, Philippa Garety, Emmanuelle Peters, Miriam Fornells-Ambrojo, Juliana Onwumere, Victoria Harris, Alison Brabban & Louise Johns. (2015) Opportunities and challenges in Improving Access to Psychological Therapies for people with Severe Mental Illness (IAPT-SMI): Evaluating the first operational year of the South London and Maudsley (SLaM) demonstration site for psychosis. Behaviour Research and Therapy 64, pages 24-30.
Crossref
Crossref
Jürgen Zielasek & Wolfgang Gaebel. 2015. International Encyclopedia of the Social & Behavioral Sciences. International Encyclopedia of the Social & Behavioral Sciences
9
15
.
Frederike Schirmbeck & Antonio Tundo. 2015. Obsessive-Compulsive Symptoms in Schizophrenia. Obsessive-Compulsive Symptoms in Schizophrenia
203
217
.
Luca Degli Esposti, Diego Sangiorgi, Claudio Mencacci, Edoardo Spina, Carlotta Pasina, Marianna Alacqua & Flore la Tour. (2014) Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study. BMC Psychiatry 14:1.
Crossref
Crossref
Nicholas Steel, Asmaa Abdelhamid, Tim Stokes, Helen Edwards, Robert Fleetcroft, Amanda Howe & Nadeem Qureshi. (2014) A review of clinical practice guidelines found that they were often based on evidence of uncertain relevance to primary care patients. Journal of Clinical Epidemiology 67:11, pages 1251-1257.
Crossref
Crossref
Petter Andreas Ringen, John A. Engh, Astrid B. Birkenaes, Ingrid Dieset & Ole A. Andreassen. (2014) Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions. Frontiers in Psychiatry 5.
Crossref
Crossref
Mathias Zink. (2014) Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment. Advances in Medicine 2014, pages 1-18.
Crossref
Crossref
Jenny García Valencia, Luisa Fernanda Ahunca Velásquez, Adriana Bohórquez Peñaranda, Carlos Gómez Restrepo, Luis Eduardo Jaramillo González & Carlos Palacio Acosta. (2014) Tratamiento con intervenciones psicoterapéuticas en la fase aguda y de mantenimiento del paciente adulto con diagnóstico de esquizofrenia. Revista Colombiana de Psiquiatría 44, pages 90-100.
Crossref
Crossref
Luisa Fernanda Ahunca Velásquez, Jenny García Valencia, Adriana Patricia Bohórquez Peñaranda, Carlos Gómez-Restrepo, Luis Eduardo Jaramillo González & Carlos Palacio Acosta. (2014) Tratamiento con intervenciones psicosociales en la fase aguda y de mantenimiento del paciente adulto con diagnóstico de esquizofrenia. Revista Colombiana de Psiquiatría 44, pages 75-89.
Crossref
Crossref
Emilio Sacchetti, Antonio Vita, Alberto Siracusano & Wolfgang FleischhackerAlex Hofer & Wolfgang Fleischhacker. 2014. Adherence to Antipsychotics in Schizophrenia. Adherence to Antipsychotics in Schizophrenia
85
97
.
A. Hasan, T. Wobrock, W. Gaebel, B. Janssen, J. Zielasek & P. Falkai. (2013) Nationale und internationale Leitlinien zur SchizophrenieNational and international schizophrenia guidelines. Der Nervenarzt 84:11, pages 1359-1368.
Crossref
Crossref
Frederike Schirmbeck & Mathias Zink. (2013) Cognitive behavioural therapy for obsessive-compulsive symptoms in schizophrenia. The Cognitive Behaviour Therapist 6.
Crossref
Crossref
Rebecca Schennach, Michael Obermeier, Florian Seemüller, Daniela Krause, Richard Musil, Ilja Spellmann, Hans-Jürgen Möller & Michael Riedel. 2013. Polypharmacy in Psychiatry Practice, Volume I. Polypharmacy in Psychiatry Practice, Volume I
137
156
.
Erik Johnsen & Rune A. Kroken. (2012) Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness. Therapeutic Advances in Chronic Disease 3:6, pages 287-300.
Crossref
Crossref